It was announced mid day yesterday December 28, 2009 that Hiru intends to acquire an east European emerging market Medical Bioresearch company on cash and stock basis (80% cash and 20% stock); HIRU management is pleased to identify the sellers identity as Hard to Treat Diseases, Inc symbol: HTDS.PK. This purchase is limited to the MindUp cancer research project.
Best Damn Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move.
Sign Up for our Free Stock Newsletter
Sign up for the free Best Damn Penny Stocks newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website
About Best Damn Penny Stocks
Best Damn Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer
